论文部分内容阅读
目的分析和探讨应用血乳酸(LAC)、血清C-反应蛋白(CRP)及红细胞分布宽度(RDW)指标对危重病患者进行早期动态监测的临床应用情况和效果。方法随机抽选2015年1月–2015年12月在该院重症监护室进行治疗的360例危重病患者,将其根据预后结果进行分组,即:非死亡组患者200例,死亡组患者160例。分别对治疗期间的LAC、CRP以及RDW指标情况进行对比、统计和分析。结果非死亡组患者在不同时间点的LAC和CRP均显著低于死亡组患者,各时间点的对比差异均有统计学意义(P<0.05)。但两组患者在不同时间点的RDW指标变化不大,对比差异均无统计学意义(P>0.05)。结论对危重病患者进行LAC、CRP早期动态监测,能够对患者的预后情况作出较为准确的判断,但RDW的效用不大。
Objective To analyze and discuss the clinical application and effect of early dynamic monitoring of critically ill patients by using LAC, CRP and RDW indexes. Methods A total of 360 critically ill patients were enrolled in the intensive care unit of our hospital from January 2015 to December 2015. The patients were divided according to the prognosis, ie 200 non-death patients and 160 death patients . The LAC, CRP and RDW indicators during treatment were compared, statistics and analysis. Results The LAC and CRP in non-death group were significantly lower than those in death group at different time points, the differences were statistically significant at all time points (P <0.05). However, there was no significant difference in RDW index between the two groups at different time points, with no significant difference between the two groups (P> 0.05). Conclusions The early dynamic monitoring of LAC and CRP in critically ill patients can make a more accurate judgment on the prognosis of patients, but RDW is of little utility.